© 2020 MJH Life Sciences and OncLive. All rights reserved.
February 10, 2020
Floor J. Backes, MD, discusses the role of PARP inhibitors as treatment of patients with ovarian cancer and her experience with these agents, such as rucaparib.
February 07, 2020
Floor J. Backes, MD, discusses quality of life with PARP inhibitors for patients with ovarian cancer.
January 23, 2020
Floor J. Backes, MD, discusses toxicity considerations with PARP inhibitors in ovarian cancer.
January 10, 2020
Floor J. Backes, MD, discusses the consideration of financial toxicity when choosing a PARP inhibitor for a patient with ovarian cancer.